Detalhe da pesquisa
1.
Tracking developmental differences in real-world social attention across adolescence, young adulthood and older adulthood.
Nat Hum Behav
; 5(10): 1381-1390, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33986520
2.
Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology.
Oncol Rep
; 17(3): 687-94, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17273752
3.
Correlations between serum monocyte chemotactic protein-1 levels, clinical prognostic factors, and HER-2/neu vaccine-related immunity in breast cancer patients.
Clin Cancer Res
; 12(2): 478-86, 2006 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16428490
4.
Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial.
Cancer
; 106(11): 2309-17, 2006 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16596621
5.
Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine.
Breast Cancer Res Treat
; 98(1): 17-29, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16758122